Skip to main content
. 2022 Nov 11;10(11):1906. doi: 10.3390/vaccines10111906

Table 8.

Application of chitosan-based complexes in RNA vaccine.

Chitosan Complex Causative Agent Diseases
Chitosan NPs [205] Influenza H9N2 HA2 and M2e mRNA Influenza
Chitosan NPs [206] Influenza virus Influenza
Chitosan–alginate hybrid hydrogel [207] Synthetic mRNAs for tissue-engineering applications Tissue-engineering applications
Mannosylated-chitosan-modified ethosomes [208] Tyrosinase-related protein 2 Melanoma